StockMacro
Menu

QuidelOrtho

$8.32 -31% in 6 monthsMarket cap $570.9M

QDEL on XNAS, Health Care, QuidelOrtho Corporation, job postings

Measures activity, not value. Not investment advice.

Quarterly revenue fell 12% and shares dropped 61% in a year while short interest stands at 21% of shares.

  • BadNet loss of $369.2M over 12 months on $2.6B of revenue

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 27 Sep 2026

QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.

Industry
In vitro & in vivo diagnostic substances (Health Care)
Employees
6,500
Website
quidelortho.com
Listed
Nasdaq, US
Last results
3 Nov 2026
Next results
expected around 10 Feb 2027 (an estimate: a year ago it reported on 11 Feb 2026)
Revenue and net income per quarter. Quarter to 27 Sep 2026: revenue $618.9M, net loss $53.8M.
Quarter to 2 Jan 2022: revenue –, net income $291.3MQuarter to 3 Apr 2022: revenue $1.0B, net income $479.9MQuarter to 3 Apr 2022: revenue $1.0B, net income $479.9MQuarter to 3 Jul 2022: revenue $613.4M, net income $19.3MQuarter to 3 Jul 2022: revenue $613.4M, net income $19.3MQuarter to 2 Oct 2022: revenue $783.8M, net income $19.2MQuarter to 2 Oct 2022: revenue $783.8M, net income $19.2MQuarter to 1 Jan 2023: revenue –, net income $30.3MQuarter to 2 Apr 2023: revenue $846.1M, net income $48.8MQuarter to 2 Apr 2023: revenue $846.1M, net income $48.8MQuarter to 2 Jul 2023: revenue $665.1M, net income -$53.2MQuarter to 2 Jul 2023: revenue $665.1M, net income -$53.2MQuarter to 1 Oct 2023: revenue $744.0M, net income -$12.7MQuarter to 1 Oct 2023: revenue $744.0M, net income -$12.7MQuarter to 31 Dec 2023: revenue –, net income $7.0MQuarter to 31 Mar 2024: revenue $711.0M, net income -$1.7BQuarter to 31 Mar 2024: revenue $711.0M, net income -$1.7BQuarter to 30 Jun 2024: revenue $637.0M, net income -$147.7MQuarter to 30 Jun 2024: revenue $637.0M, net income -$147.7MQuarter to 29 Sep 2024: revenue $727.1M, net income -$19.9MQuarter to 29 Sep 2024: revenue $727.1M, net income -$19.9MQuarter to 29 Dec 2024: revenue $707.8M, net income -$178.4MQuarter to 29 Dec 2024: revenue $707.8M, net income -$178.4MQuarter to 30 Mar 2025: revenue $692.8M, net income -$12.7MQuarter to 30 Mar 2025: revenue $692.8M, net income -$12.7MQuarter to 29 Jun 2025: revenue $613.9M, net income -$255.4MQuarter to 29 Jun 2025: revenue $613.9M, net income -$255.4MQuarter to 28 Sep 2025: revenue $699.9M, net income -$733.0MQuarter to 28 Sep 2025: revenue $699.9M, net income -$733.0MQuarter to 28 Dec 2025: revenue $723.6M, net income -$130.7MQuarter to 28 Dec 2025: revenue $723.6M, net income -$130.7MQuarter to 29 Mar 2026: revenue $619.8M, net income -$91.8MQuarter to 29 Mar 2026: revenue $619.8M, net income -$91.8MQuarter to 28 Jun 2026: revenue $630.9M, net income -$92.9MQuarter to 28 Jun 2026: revenue $630.9M, net income -$92.9MQuarter to 27 Sep 2026: revenue $618.9M, net income -$53.8MQuarter to 27 Sep 2026: revenue $618.9M, net income -$53.8M
2 Jan 2022RevenueNet incomeNet losstallest bar $1.7B27 Sep 2026
See the numbers
Quarter toRevenueNet income
27 Sep 2026$618.9M-$53.8M
28 Jun 2026$630.9M-$92.9M
29 Mar 2026$619.8M-$91.8M
28 Dec 2025$723.6M-$130.7M
28 Sep 2025$699.9M-$733.0M
29 Jun 2025$613.9M-$255.4M
30 Mar 2025$692.8M-$12.7M
29 Dec 2024$707.8M-$178.4M
29 Sep 2024$727.1M-$19.9M
30 Jun 2024$637.0M-$147.7M
31 Mar 2024$711.0M-$1.7B
31 Dec 2023–$7.0M
1 Oct 2023$744.0M-$12.7M
2 Jul 2023$665.1M-$53.2M
2 Apr 2023$846.1M$48.8M
1 Jan 2023–$30.3M
2 Oct 2022$783.8M$19.2M
3 Jul 2022$613.4M$19.3M
3 Apr 2022$1.0B$479.9M
2 Jan 2022–$291.3M
Fundamentals, 12 months to 27 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $2.6B $2.7B
Revenue growthRevenue of the last 12 months compared with the 12 months before. -4.5% -1.5%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. -$369.2M -$1.2B
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). -$5.39 -$17.36
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. – – 51.3%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. -4.9% -35.1% -9.6%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. -14.2% -43.5% -15.2%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. -19.3% -40.2%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. – -$153.1M
CashCash, cash equivalents and short-term investments on the latest balance sheet. $166.4M $98.1M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $2.9B $2.7B
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). $2.8B $2.6B
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. 1.6 0.22
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $26.11
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. loss 24.7
P/SPrice to sales: market cap divided by revenue of the last 12 months. 0.22 3.6
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. 1.3 3.6
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 0.32 2.3

Latest = 12 months to 27 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
QuidelOrthoQDEL (this company) $570.9Mloss0.22-4.5%-14.2%
Achieve Life SciencesQUIT $611.8Mloss–––
Myriad GeneticsMYGN $523.7Mloss0.65-2.6%-16.1%
Alpha TeknovaTKNO $480.0Mloss10.4+15%-34.8%
Intellia TherapeuticsNTLA $1.4Bloss26.5-8.1%-806%
Celldex TherapeuticsCLDX $2.2Bloss–––

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

–

No data for this company

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

-0.8%

240 13F filers vs 242

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

over 100%

81.7M shares held by 13F filers (30 Sep 2026) of 68.6M outstanding (28 Oct 2026); above 100%: the share count is probably stale

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

21%

14.5M shares sold short (30 Oct 2026) of 68.6M outstanding (28 Oct 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

7.6

14.5M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

+11%

13.0M shares sold short in the report before, 14.5M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

63%

63% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 57%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

17

Tracked since 21 Nov 2026

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

Tracking started 21 Nov 2026; the change shows after 30 days.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

–

No data for this company

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

-12%

$618.9M vs $699.9M (quarter ended 27 Sep 2026)

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

-32%

$25.5M vs $37.5M (quarter ended 28 Jun 2026)

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

–

No data for this company

Lobbying What the company reported spending on federal lobbying over the last four quarters.

$180K

4 quarters, $

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

12

12 articles in the last 7 days; its usual week has 1 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

12×

12 articles in the last 7 days; its usual week has 1.

Price $8.32 on 20 Nov 2026, -61% over 12 months (12-month range $8.32 to $35.38)

  • Sharp change
  • 8-K and other filings
  • Lobbying filing
Insider net buying (open market). Insiders bought a net $600K in the last 12 months (the 12 months before: $786K).
H-1B/E-3 applications certified. H-1B/E-3 applications certified: 3 published in the last 12 months (none in the 12 months before).
Revenue per quarter. Revenue $618.9M in the latest quarter, -12% on a year earlier.
Capital spending per quarter. Capital spending $25.5M in the latest quarter, -32% on a year earlier.
Institutional holders (13F filers). 240 13F filers reported holding it in the latest 13F quarter, -0.4% on a year earlier.
Federal obligations. Federal obligations: $5.7M published in the last 12 months (none in the 12 months before).
Lobbying spend. Lobbying spend: $180K published in the last 12 months, -10% on the 12 months before.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
3 Nov 20268-K and other filingsDirector or officer change
3 Nov 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
23 Jun 20268-K and other filingsDirector or officer change
23 Jun 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
24 Mar 20268-K and other filingsDirector or officer change
13 Feb 20268-K and other filingsDirector or officer change
5 Feb 20268-K and other filingsDirector or officer change
5 Feb 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
30 Dec 2025Sharp changeShort interest spike: short interest spike, 11.3M vs usual 4.4M (2025-12-15); 3.0x the same period a year earlier
16 Dec 2025Sharp changeShort interest spike: short interest spike, 11.5M vs usual 4.3M (2025-11-28); 2.9x the same period a year earlier
2 Dec 2025Sharp changeShort interest spike: short interest spike, 11.1M vs usual 4.3M (2025-11-14); 2.9x the same period a year earlier
26 Nov 2025Sharp changeClustered insider buying: clustered insider buying (3 independent filers, 3 filing(s) in 30 days, value_usd total 648K)
18 Nov 2025Sharp changeShort interest spike: short interest spike, 9.0M vs usual 4.2M (2025-10-31); 2.2x the same period a year earlier
28 Oct 2025Sharp changeShort interest spike: short interest spike, 8.4M vs usual 4.2M (2025-10-15); 2.0x the same period a year earlier
14 Oct 2025Sharp changeShort interest spike: short interest spike, 8.7M vs usual 4.2M (2025-09-30); 2.1x the same period a year earlier
30 Sep 2025Sharp changeShort interest spike: short interest spike, 8.2M vs usual 4.2M (2025-09-15); 2.0x the same period a year earlier
16 Sep 2025Sharp changeShort interest spike: short interest spike, 7.6M vs usual 4.2M (2025-08-29); 1.8x the same period a year earlier
2 Sep 2025Sharp changeShort interest spike: short interest spike, 7.3M vs usual 4.2M (2025-08-15); 1.8x the same period a year earlier
12 Aug 2025Sharp changeShort interest spike: short interest spike, 6.6M vs usual 4.2M (2025-07-31); 1.5x the same period a year earlier
29 Jul 2025Sharp changeShort interest spike: short interest spike, 6.2M vs usual 4.1M (2025-07-15); 1.7x the same period a year earlier
27 May 20258-K and other filingsDirector or officer change
27 May 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
4 Mar 20258-K and other filingsChanged its auditor
10 Dec 20248-K and other filingsDirector or officer change
21 Nov 20248-K and other filingsDirector or officer change
18 Nov 20248-K and other filingsDirector or officer change
8 Nov 20248-K and other filingsDirector or officer change
8 Nov 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
7 May 20248-K and other filingsDirector or officer change
21 Feb 20248-K and other filingsDirector or officer change
2 Jan 2024Sharp changeShort interest spike: short interest spike, 4.0M vs usual 2.7M (2023-12-15); 1.5x the same period a year earlier
12 Dec 2023Sharp changeShort interest spike: short interest spike, 3.8M vs usual 2.7M (2023-11-30); 1.4x the same period a year earlier
1 Dec 20238-K and other filingsDirector or officer change
1 Dec 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
18 Aug 20238-K and other filingsDirector or officer change
18 Aug 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
9 May 2023Sharp changeQuarterly capital spending jump: quarterly capital spending jump, 66.0M vs usual 31.4M (2023-04-02); 2.9x the same period a year earlier
10 Apr 20238-K and other filingsDirector or officer change
10 Apr 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
13 Dec 20228-K and other filingsDirector or officer change
13 Dec 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
6 Jun 20228-K and other filingsDirector or officer change
6 Jun 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
17 Mar 2022Lobbying filingnew lobbying registration (BURRELL INTERNATIONAL GROUP LLC)
Insider net buying (open market)
Month from 1 Feb 2023: -$729K published
Month from 1 Feb 2024: $100K published
Month from 1 Jun 2024: -$30.2M published
Month from 1 Jul 2024: -$76.8M published
Month from 1 Aug 2024: -$48.2M published
Month from 1 Nov 2024: -$291.7M published
Month from 1 Dec 2024: $250K published
Month from 1 Nov 2025: $536K published
Month from 1 Dec 2025: $32K published
Month from 1 Feb 2026: $568K published
H-1B/E-3 applications certified
Quarter from 1 Oct 2026: 3 published
Revenue per quarter
Quarter ended 4 Jul 2021: $176.6M; public on 6 Aug 2022
Quarter ended 3 Oct 2021: $509.8M; public on 5 Nov 2022
Quarter ended 3 Apr 2022: $1.0B; public on 5 May 2023
Quarter ended 3 Jul 2022: $613.4M, +247% on a year earlier; public on 6 Aug 2022
Quarter ended 2 Oct 2022: $783.8M, +54% on a year earlier; public on 5 Nov 2022
Quarter ended 2 Apr 2023: $846.1M, -16% on a year earlier; public on 5 May 2023
Quarter ended 2 Jul 2023: $665.1M, +8.4% on a year earlier; public on 10 Aug 2023
Quarter ended 1 Oct 2023: $744.0M, -5.1% on a year earlier; public on 3 Nov 2023
Quarter ended 31 Mar 2024: $711.0M, -16% on a year earlier; public on 10 May 2024
Quarter ended 30 Jun 2024: $637.0M, -4.2% on a year earlier; public on 2 Aug 2024
Quarter ended 29 Sep 2024: $727.1M, -2.3% on a year earlier; public on 9 Nov 2024
Quarter ended 29 Dec 2024: $707.8M; public on 28 Feb 2025
Quarter ended 30 Mar 2025: $692.8M, -2.6% on a year earlier; public on 9 May 2025
Quarter ended 29 Jun 2025: $613.9M, -3.6% on a year earlier; public on 7 Aug 2025
Quarter ended 28 Sep 2025: $699.9M, -3.7% on a year earlier; public on 7 Nov 2025
Quarter ended 28 Dec 2025: $723.6M, +2.2% on a year earlier; public on 20 Feb 2026
Quarter ended 29 Mar 2026: $619.8M, -11% on a year earlier; public on 7 May 2026
Quarter ended 28 Jun 2026: $630.9M, +2.8% on a year earlier; public on 8 Aug 2026
Quarter ended 27 Sep 2026: $618.9M, -12% on a year earlier; public on 5 Nov 2026
Capital spending per quarter
Quarter ended 3 Oct 2021: $106.9M; public on 5 Nov 2022
Quarter ended 2 Jan 2022: $32.4M; public on 24 Feb 2023
Quarter ended 3 Apr 2022: $22.5M; public on 5 May 2023
Quarter ended 3 Jul 2022: $26.2M; public on 6 Aug 2022
Quarter ended 2 Oct 2022: $30.5M, -71% on a year earlier; public on 5 Nov 2022
Quarter ended 1 Jan 2023: $61.7M, +90% on a year earlier; public on 24 Feb 2023
Quarter ended 2 Apr 2023: $66.0M, +193% on a year earlier; public on 5 May 2023
Quarter ended 2 Jul 2023: $51.3M, +96% on a year earlier; public on 10 Aug 2023
Quarter ended 1 Oct 2023: $43.4M, +42% on a year earlier; public on 3 Nov 2023
Quarter ended 31 Dec 2023: $48.6M, -21% on a year earlier; public on 1 Mar 2024
Quarter ended 31 Mar 2024: $66.1M, +0.2% on a year earlier; public on 10 May 2024
Quarter ended 30 Jun 2024: $35.3M, -31% on a year earlier; public on 2 Aug 2024
Quarter ended 29 Sep 2024: $46.5M, +7.1% on a year earlier; public on 9 Nov 2024
Quarter ended 29 Dec 2024: $47.2M, -2.9% on a year earlier; public on 28 Feb 2025
Quarter ended 30 Mar 2025: $56.2M, -15% on a year earlier; public on 9 May 2025
Quarter ended 29 Jun 2025: $37.5M, +6.2% on a year earlier; public on 7 Aug 2025
Quarter ended 28 Sep 2025: $49.2M, +5.8% on a year earlier; public on 7 Nov 2025
Quarter ended 28 Dec 2025: $45.3M, -4.0% on a year earlier; public on 20 Feb 2026
Quarter ended 29 Mar 2026: $34.0M, -40% on a year earlier; public on 7 May 2026
Quarter ended 28 Jun 2026: $25.5M, -32% on a year earlier; public on 8 Aug 2026
Institutional holders (13F filers)
31 Dec 2021 report: 326; public on 14 Feb 2022
31 Mar 2022 report: 334; public on 16 May 2022
30 Jun 2022 report: 324; public on 15 Aug 2022
30 Sep 2022 report: 285; public on 14 Nov 2022
31 Dec 2022 report: 318; public on 14 Feb 2023
31 Mar 2023 report: 305; public on 15 May 2023
30 Jun 2023 report: 291; public on 14 Aug 2023
30 Sep 2023 report: 284; public on 14 Nov 2023
31 Dec 2023 report: 288; public on 14 Feb 2024
31 Mar 2024 report: 258; public on 15 May 2024
30 Jun 2024 report: 248; public on 14 Aug 2024
30 Sep 2024 report: 249; public on 14 Nov 2024
31 Dec 2024 report: 267; public on 14 Feb 2025
31 Mar 2025 report: 254; public on 15 May 2025
30 Jun 2025 report: 252; public on 14 Aug 2025
30 Sep 2025 report: 241; public on 14 Nov 2025
31 Dec 2025 report: 232; public on 17 Feb 2026
31 Mar 2026 report: 228; public on 15 May 2026
30 Jun 2026 report: 242; public on 14 Aug 2026
30 Sep 2026 report: 240; public on 16 Nov 2026
Federal obligations
Month from 1 Nov 2026: $5.7M published
Lobbying spend
Quarter from 1 Apr 2022: $10K published
Quarter from 1 Jul 2022: $30K published
Quarter from 1 Oct 2022: $30K published
Quarter from 1 Jan 2023: $30K published
Quarter from 1 Apr 2023: $30K published
Quarter from 1 Jul 2023: $40K published
Quarter from 1 Oct 2023: $40K published
Quarter from 1 Jan 2024: $50K published
Quarter from 1 Apr 2024: $50K published
Quarter from 1 Jul 2024: $50K published
Quarter from 1 Oct 2024: $50K published
Quarter from 1 Jan 2025: $50K published
Quarter from 1 Apr 2025: $50K published
Quarter from 1 Jul 2025: $50K published
Quarter from 1 Oct 2025: $50K published
Quarter from 1 Jan 2026: $50K published
Quarter from 1 Apr 2026: $50K published
Quarter from 1 Jul 2026: $40K published
Quarter from 1 Oct 2026: $40K published

What is unusual now

  • Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is insider open-market buying (USD, Form 4) at $568K (13 Feb 2026), 110× its normal reading; higher than 100% of its own history.
  • Insider net buying (open market): Insiders bought a net $600K in the last 12 months (the 12 months before: $786K).
  • H-1B/E-3 applications certified: H-1B/E-3 applications certified: 3 published in the last 12 months (none in the 12 months before).
  • Revenue per quarter: Revenue $618.9M in the latest quarter, -12% on a year earlier.

Latest records

The names and amounts behind the totals, newest first

Insider trades

All 35 insider trades

No trades in the last 90 days; the latest was filed 13 Feb 2026. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
13 Feb 2026Matthew StrobeckDirectorBuy10,000$23.96$240KForm 4
13 Feb 2026Brian J. BlaserPresident and CEOBuy10,540$23.59$249KForm 4
13 Feb 2026Joseph M. BuskyChief Financial OfficerBuy3,370$23.66$80KForm 4
10 Dec 2025Ann D RhoadsDirectorBuy750$28.28$21KForm 4
1 Dec 2025Joseph D Wilkins Jr.DirectorBuy370$27.96$10KForm 4
25 Nov 2025Joseph M. BuskyChief Financial OfficerBuy4,770$26.06$124KForm 4
25 Nov 2025Kenneth J WidderDirectorSellafter exercising options4,026$27.81$112KForm 4
24 Nov 2025Polan Mary Lake Ph DDirectorBuy1,000$22.43$22KForm 4

240 institutions reported shares at the end of Q3 2026, 100% of the shares outstanding; 41 opened a position, 46 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
BlackRock, Inc.11.1M16.2%$117.4M-60K-0.5%
Newtyn Management, LLC5.3M7.79%$56.3M-1.3M-19%
FMR LLC (Fidelity)4.0M5.76%$41.6M-3.4M-46%
American Century Companies Inc3.9M5.72%$41.4M+620K+19%
Vanguard Portfolio Management LLC3.6M5.30%$38.3M-500K-12%
Invesco Ltd.3.6M5.25%$38.0M+131K+3.8%
Rubric Capital Management LP3.1M4.57%$33.0M-173K-5.2%
State Street Corp3.0M4.41%$31.9M+48K+1.6%
Vanguard Capital Management LLC3.0M4.40%$31.8M-54K-1.8%
Neuberger Berman Group LLC2.9M4.30%$31.1M-585K-17%

Company events

All 21 company events

In 12 months: 5 director or officer changes, 1 major agreement. Results releases and routine reports are left out.

FiledWhat happenedSource
3 Nov 2026Director or officer change8-K
23 Sep 2026Signed a major agreement8-K
23 Jun 2026Director or officer change8-K
24 Mar 2026Director or officer change8-K
13 Feb 2026Director or officer change8-K
5 Feb 2026Director or officer change8-K
21 Aug 2025Signed a major agreementSame filing: took on new debt8-K
27 May 2025Director or officer changeSame filing: shareholder vote results8-K

17 open postings; careers site tracked since 21 Nov 2026. Most in Manufacturing & production 35%, Data & analytics 6%, Marketing & communications 6%, People & recruiting 6%.

PostedJobLocation
21 Nov 2026or earlierSr. Manager, Systems Engineering, Point-Of-CareUS - CA - San Diego - Summers Ridge
21 Nov 2026or earlierHR GeneralistPeople & recruitingUS - NY - Rochester
21 Nov 2026or earlierSenior Process Engineer (R&D)Process engineering (semiconductor / materials)US - NY - Rochester
21 Nov 2026or earlierSenior Marketing Manager, Customer Informatics – North AmericaMarketing & communicationsUS - Work From Home
21 Nov 2026or earlierSAMS Slides Assembly Operator II, IIIManufacturing & productionUS - NY - Rochester
21 Nov 2026or earlierFilm Coating Operator II, IIIUS - NY - Rochester
21 Nov 2026or earlierSenior Global Azure Data EngineerData & analyticsCzechia
20 Nov 2026Automated Maintenance Technician IIIManufacturing & productionUS - NY - Rochester

Reported lobbying spend: $40K in Q3 2026, $40K in Q2 2026. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.

DateChangeLobbying firmIssueSource
8 Feb 2022NewBurrell International Group LLCfor Apco Worldwide LLC (On Behalf Of Quidelortho)Warm base manufacturing, over the counter diagnostic testing, and pandemic preparednessMED, Health issuesFiling
30 Apr 2021EndedThe Nickles Group, LLCfor Ortho-Clinical Diagnostics, Inc.Funding issues related to antibody & antigen tests for COVID-19.; Implementation issues related to H.R. 133, the Consolidated Appropriations Act of 2021, pertaining to COVID testing. Implementation issues related to P.L. 117-2, the American Rescue Plan, as it relates to COVID testing.; Implementation issues related to P.L. 116-139, the Paycheck Protection Program and Healthcare Enhancement Act; funding issues related to antibody & antigen tests for COVID-19; implementation issues related to H.R. 133, the Consolidated Appropriations Act of 2021, pertaining to COVID testing. ImplemeDefense, Government issues, Health issuesFiling
31 Jan 2021EndedChristie 55 Solutions LLCfor Christie Law Firm LLC On Behalf Of Ortho Clinical Diagnostics, Inc.Issues related to in vitro diagnostic testing for COVID-19.Health issuesFiling
21 Dec 2020NewChristie 55 Solutions LLCfor Christie Law Firm LLC On Behalf Of Ortho Clinical Diagnostics, Inc.Issues related to in vitro diagnostic testing for COVID-19.Health issuesFiling
1 May 2020NewThe Nickles Group, LLCfor Ortho-Clinical Diagnostics, Inc.Issues related to COVID-19 and antibody testing.Health issuesFiling

The 5 newest of 114 articles that name the company.

Timeline

Several things at once

Two or more unrelated kinds of records unusual within 30 days

26 Nov 2025confirmed

Confirmed across sources Insiders and Short interest and volume

QuidelOrtho (QDEL): had 3 insiders buy $648K of its shares on the open market within 30 days (3 filings), while it had 11.5M shares sold short in the 28 Nov 2025 report, 2.9× the same report last year. Two unrelated kinds of activity within 63 days.

  • Short interest and volume: Short interest spike, became public on 25 Oct 2025
  • Short interest and volume: Short interest spike, became public on 13 Nov 2025
  • Insiders: Clustered insider buying, became public on 26 Nov 2025
  • Short interest and volume: Short interest spike, became public on 26 Nov 2025
  • Short interest and volume: Short interest spike, became public on 10 Dec 2025
  • Short interest and volume: Short interest spike, became public on 25 Dec 2025
2024-11-29: 3.9M2024-12-13: 3.8M2024-12-31: 4.2M2025-01-15: 4.1M2025-01-31: 3.4M2025-02-14: 4.3M2025-02-28: 4.3M2025-03-14: 4.4M2025-03-31: 4.1M2025-04-15: 3.8M2025-04-30: 4.3M2025-05-15: 4.2M2025-05-30: 3.9M2025-06-13: 4.1M2025-06-30: 5.9M2025-07-15: 6.2M2025-07-31: 6.6M2025-08-15: 7.3M2025-08-29: 7.6M2025-09-15: 8.2M2025-09-30: 8.7M2025-10-15: 8.4M2025-10-31: 9.0M2025-11-14: 11.1M2025-11-28: 11.5M
The 28 Nov 2025 report against the 24 reports before it. this reportearliernormal: 4.3M
See the evidence (6 changes)

Short interest and volume: Short interest spike became public on 25 Oct 2025

QuidelOrtho had 8.4M shares sold short in the 15 Oct 2025 report, 2.0× the same report last year.

This period
8.4M (the 15 Oct 2025 report)
Normal report (median of 24 earlier)
4.2M
Typical spread (median absolute deviation)
323K
How far from its usual level
+8.7
Same report last year
4.2M
History used
2,847 days
2024-10-15: 4.2M2024-10-31: 4.1M2024-11-15: 3.8M2024-11-29: 3.9M2024-12-13: 3.8M2024-12-31: 4.2M2025-01-15: 4.1M2025-01-31: 3.4M2025-02-14: 4.3M2025-02-28: 4.3M2025-03-14: 4.4M2025-03-31: 4.1M2025-04-15: 3.8M2025-04-30: 4.3M2025-05-15: 4.2M2025-05-30: 3.9M2025-06-13: 4.1M2025-06-30: 5.9M2025-07-15: 6.2M2025-07-31: 6.6M2025-08-15: 7.3M2025-08-29: 7.6M2025-09-15: 8.2M2025-09-30: 8.7M2025-10-15: 8.4M
the 15 Oct 2025 report24 earlier reportsnormal: 4.2M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 13 Nov 2025

QuidelOrtho had 9.0M shares sold short in the 31 Oct 2025 report, 2.2× the same report last year.

This period
9.0M (the 31 Oct 2025 report)
Normal report (median of 24 earlier)
4.2M
Typical spread (median absolute deviation)
377K
How far from its usual level
+8.5
Same report last year
4.1M
History used
2,863 days
2024-10-31: 4.1M2024-11-15: 3.8M2024-11-29: 3.9M2024-12-13: 3.8M2024-12-31: 4.2M2025-01-15: 4.1M2025-01-31: 3.4M2025-02-14: 4.3M2025-02-28: 4.3M2025-03-14: 4.4M2025-03-31: 4.1M2025-04-15: 3.8M2025-04-30: 4.3M2025-05-15: 4.2M2025-05-30: 3.9M2025-06-13: 4.1M2025-06-30: 5.9M2025-07-15: 6.2M2025-07-31: 6.6M2025-08-15: 7.3M2025-08-29: 7.6M2025-09-15: 8.2M2025-09-30: 8.7M2025-10-15: 8.4M2025-10-31: 9.0M
the 31 Oct 2025 report24 earlier reportsnormal: 4.2M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Insiders: Clustered insider buying became public on 26 Nov 2025

QuidelOrtho had 3 insiders buy $648K of its shares on the open market within 30 days (3 filings).

Independent buyers
3
Purchase filings (Form 4, code P)
3
Total bought
$648K
Window
27 Oct 2025 to 26 Nov 2025

Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

Short interest and volume: Short interest spike became public on 26 Nov 2025

QuidelOrtho had 11.1M shares sold short in the 14 Nov 2025 report, 2.9× the same report last year.

This period
11.1M (the 14 Nov 2025 report)
Normal report (median of 24 earlier)
4.3M
Typical spread (median absolute deviation)
458K
How far from its usual level
+10.0
Same report last year
3.8M
History used
2,877 days
2024-11-15: 3.8M2024-11-29: 3.9M2024-12-13: 3.8M2024-12-31: 4.2M2025-01-15: 4.1M2025-01-31: 3.4M2025-02-14: 4.3M2025-02-28: 4.3M2025-03-14: 4.4M2025-03-31: 4.1M2025-04-15: 3.8M2025-04-30: 4.3M2025-05-15: 4.2M2025-05-30: 3.9M2025-06-13: 4.1M2025-06-30: 5.9M2025-07-15: 6.2M2025-07-31: 6.6M2025-08-15: 7.3M2025-08-29: 7.6M2025-09-15: 8.2M2025-09-30: 8.7M2025-10-15: 8.4M2025-10-31: 9.0M2025-11-14: 11.1M
the 14 Nov 2025 report24 earlier reportsnormal: 4.3M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 10 Dec 2025

QuidelOrtho had 11.5M shares sold short in the 28 Nov 2025 report, 2.9× the same report last year.

This period
11.5M (the 28 Nov 2025 report)
Normal report (median of 24 earlier)
4.3M
Typical spread (median absolute deviation)
524K
How far from its usual level
+9.2
Same report last year
3.9M
History used
2,891 days
2024-11-29: 3.9M2024-12-13: 3.8M2024-12-31: 4.2M2025-01-15: 4.1M2025-01-31: 3.4M2025-02-14: 4.3M2025-02-28: 4.3M2025-03-14: 4.4M2025-03-31: 4.1M2025-04-15: 3.8M2025-04-30: 4.3M2025-05-15: 4.2M2025-05-30: 3.9M2025-06-13: 4.1M2025-06-30: 5.9M2025-07-15: 6.2M2025-07-31: 6.6M2025-08-15: 7.3M2025-08-29: 7.6M2025-09-15: 8.2M2025-09-30: 8.7M2025-10-15: 8.4M2025-10-31: 9.0M2025-11-14: 11.1M2025-11-28: 11.5M
the 28 Nov 2025 report24 earlier reportsnormal: 4.3M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 25 Dec 2025

QuidelOrtho had 11.3M shares sold short in the 15 Dec 2025 report, 3.0× the same report last year.

This period
11.3M (the 15 Dec 2025 report)
Normal report (median of 24 earlier)
4.4M
Typical spread (median absolute deviation)
770K
How far from its usual level
+6.1
Same report last year
3.8M
History used
2,908 days
2024-12-13: 3.8M2024-12-31: 4.2M2025-01-15: 4.1M2025-01-31: 3.4M2025-02-14: 4.3M2025-02-28: 4.3M2025-03-14: 4.4M2025-03-31: 4.1M2025-04-15: 3.8M2025-04-30: 4.3M2025-05-15: 4.2M2025-05-30: 3.9M2025-06-13: 4.1M2025-06-30: 5.9M2025-07-15: 6.2M2025-07-31: 6.6M2025-08-15: 7.3M2025-08-29: 7.6M2025-09-15: 8.2M2025-09-30: 8.7M2025-10-15: 8.4M2025-10-31: 9.0M2025-11-14: 11.1M2025-11-28: 11.5M2025-12-15: 11.3M
the 15 Dec 2025 report24 earlier reportsnormal: 4.4M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

20 Jul 2021confirmed

Confirmed across sources Lobbying and Short interest and volume

QuidelOrtho (QDEL): had 5.0M shares sold short in the 15 Jun 2021 report, 2.4× the same report last year, while it lobbying on a new issue. Two unrelated kinds of activity within 28 days.

  • Short interest and volume: Short interest spike, became public on 26 Jun 2021
  • Lobbying: Lobbying on a new issue, became public on 20 Jul 2021
  • Short interest and volume: Short interest spike, became public on 27 Jul 2021
2020-06-15: 2.1M2020-06-30: 2.7M2020-07-15: 2.3M2020-07-31: 1.9M2020-08-14: 1.8M2020-08-31: 2.1M2020-09-15: 2.6M2020-09-30: 2.8M2020-10-15: 2.6M2020-10-30: 2.4M2020-11-13: 2.5M2020-11-30: 2.4M2020-12-15: 2.2M2020-12-31: 2.1M2021-01-15: 2.7M2021-01-29: 2.6M2021-02-12: 2.4M2021-02-26: 3.2M2021-03-15: 3.6M2021-03-31: 4.1M2021-04-15: 3.8M2021-04-30: 4.2M2021-05-14: 4.6M2021-05-28: 4.6M2021-06-15: 5.0M
The 15 Jun 2021 report against the 24 reports before it. this reportearliernormal: 2.6M
See the evidence (3 changes)

Short interest and volume: Short interest spike became public on 26 Jun 2021

QuidelOrtho had 5.0M shares sold short in the 15 Jun 2021 report, 2.4× the same report last year.

This period
5.0M (the 15 Jun 2021 report)
Normal report (median of 24 earlier)
2.6M
Typical spread (median absolute deviation)
432K
How far from its usual level
+3.8
Same report last year
2.1M
History used
1,264 days
2020-06-15: 2.1M2020-06-30: 2.7M2020-07-15: 2.3M2020-07-31: 1.9M2020-08-14: 1.8M2020-08-31: 2.1M2020-09-15: 2.6M2020-09-30: 2.8M2020-10-15: 2.6M2020-10-30: 2.4M2020-11-13: 2.5M2020-11-30: 2.4M2020-12-15: 2.2M2020-12-31: 2.1M2021-01-15: 2.7M2021-01-29: 2.6M2021-02-12: 2.4M2021-02-26: 3.2M2021-03-15: 3.6M2021-03-31: 4.1M2021-04-15: 3.8M2021-04-30: 4.2M2021-05-14: 4.6M2021-05-28: 4.6M2021-06-15: 5.0M
the 15 Jun 2021 report24 earlier reportsnormal: 2.6M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Lobbying: Lobbying on a new issue became public on 20 Jul 2021

QuidelOrtho lobbying on a new issue.

New
['DEF', 'GOV']
Rule
only points whose every posting (and value revision) is at or before as_of
Field
issue_codes
Metric
lobbying.filings_count
Point id
12723363

Short interest and volume: Short interest spike became public on 27 Jul 2021

QuidelOrtho had 5.7M shares sold short in the 15 Jul 2021 report, 2.5× the same report last year.

This period
5.7M (the 15 Jul 2021 report)
Normal report (median of 24 earlier)
2.6M
Typical spread (median absolute deviation)
538K
How far from its usual level
+3.8
Same report last year
2.3M
History used
1,294 days
2020-07-15: 2.3M2020-07-31: 1.9M2020-08-14: 1.8M2020-08-31: 2.1M2020-09-15: 2.6M2020-09-30: 2.8M2020-10-15: 2.6M2020-10-30: 2.4M2020-11-13: 2.5M2020-11-30: 2.4M2020-12-15: 2.2M2020-12-31: 2.1M2021-01-15: 2.7M2021-01-29: 2.6M2021-02-12: 2.4M2021-02-26: 3.2M2021-03-15: 3.6M2021-03-31: 4.1M2021-04-15: 3.8M2021-04-30: 4.2M2021-05-14: 4.6M2021-05-28: 4.6M2021-06-15: 5.0M2021-06-30: 4.9M2021-07-15: 5.7M
the 15 Jul 2021 report24 earlier reportsnormal: 2.6M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

19 May 2020confirmed

Confirmed across sources Institutional holdings and Lobbying

QuidelOrtho (QDEL): registered for federal lobbying for the first time in our data (The Nickles Group, Llc), while it saw 73 13F filers open a new position in the quarter ended 31 Mar 2020, 2.0× the same quarter last year. Two unrelated kinds of activity within 1 day.

  • Lobbying: First lobbying registration, became public on 18 May 2020
  • Institutional holdings: Many funds opening a new position, became public on 15 May 2020
2018-03-31: 302018-06-30: 362018-09-30: 262018-12-31: 222019-03-31: 362019-06-30: 102019-09-30: 192019-12-31: 162020-03-31: 73
The quarter ended 31 Mar 2020 against the 8 quarters before it. this quarterearliernormal: 24
See the evidence (2 changes)

Lobbying: First lobbying registration became public on 18 May 2020

QuidelOrtho registered for federal lobbying for the first time in our data (The Nickles Group, Llc).

Source coverage starts
5 Oct 2010
Earlier events of other kinds
0

"First" means first in our data: it fires only when the source's history began at least 365 days earlier.

Institutional holdings: Many funds opening a new position became public on 15 May 2020

QuidelOrtho saw 73 13F filers open a new position in the quarter ended 31 Mar 2020, 2.0× the same quarter last year.

This period
73 (the quarter ended 31 Mar 2020)
Normal quarter (median of 8 earlier)
24
Typical spread (median absolute deviation)
7
How far from its usual level
+4.7
Same quarter last year
36
History used
2,374 days
2018-03-31: 302018-06-30: 362018-09-30: 262018-12-31: 222019-03-31: 362019-06-30: 102019-09-30: 192019-12-31: 162020-03-31: 73
the quarter ended 31 Mar 20208 earlier quartersnormal: 24

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

Check it at the source: SEC Form 13F data sets.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

Timeline

Changes and notable records, by the date each became public

  1. 3 Nov 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  2. 3 Nov 2026Filings record

    Director or officer change

  3. 23 Jun 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  4. 23 Jun 2026Filings record

    Director or officer change

  5. 24 Mar 2026Filings record

    Director or officer change

  6. 20 Feb 2026Insiders record

    Busky Joseph M. (Chief Financial Officer) bought 3,370 shares of QDEL [amended] [same transaction as an earlier filing] (dated 19 Feb 2026)

  7. 14 Feb 2026Insiders record

    Strobeck Matthew (director) bought 10,000 shares of QDEL ($239,600) (dated 13 Feb 2026)

  8. 14 Feb 2026Insiders record

    Blaser Brian J. (President and CEO) bought 10,540 shares of QDEL ($248,639) (dated 13 Feb 2026)

  9. 14 Feb 2026Insiders record

    Busky Joseph M. (Chief Financial Officer) bought 3,370 shares of QDEL ($79,734) (dated 13 Feb 2026)

  10. 13 Feb 2026Filings record

    Director or officer change

  11. 5 Feb 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  12. 5 Feb 2026Filings record

    Director or officer change

  13. 25 Dec 2025Short interest and volume change

    had 11.3M shares sold short in the 15 Dec 2025 report, 3.0× the same report last year.

    Same report last year: 3.8M; its normal report is 4.4M.

    See the evidence
    This period
    11.3M (the 15 Dec 2025 report)
    Normal report (median of 24 earlier)
    4.4M
    Typical spread (median absolute deviation)
    770K
    How far from its usual level
    +6.1
    Same report last year
    3.8M
    History used
    2,908 days
    2024-12-13: 3.8M2024-12-31: 4.2M2025-01-15: 4.1M2025-01-31: 3.4M2025-02-14: 4.3M2025-02-28: 4.3M2025-03-14: 4.4M2025-03-31: 4.1M2025-04-15: 3.8M2025-04-30: 4.3M2025-05-15: 4.2M2025-05-30: 3.9M2025-06-13: 4.1M2025-06-30: 5.9M2025-07-15: 6.2M2025-07-31: 6.6M2025-08-15: 7.3M2025-08-29: 7.6M2025-09-15: 8.2M2025-09-30: 8.7M2025-10-15: 8.4M2025-10-31: 9.0M2025-11-14: 11.1M2025-11-28: 11.5M2025-12-15: 11.3M
    the 15 Dec 2025 report24 earlier reportsnormal: 4.4M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  14. 11 Dec 2025Insiders record

    RHOADS ANN D (director) bought 750 shares of QDEL ($21,210) (dated 10 Dec 2025)

  15. 10 Dec 2025Short interest and volume change

    had 11.5M shares sold short in the 28 Nov 2025 report, 2.9× the same report last year.

    Same report last year: 3.9M; its normal report is 4.3M.

    See the evidence
    This period
    11.5M (the 28 Nov 2025 report)
    Normal report (median of 24 earlier)
    4.3M
    Typical spread (median absolute deviation)
    524K
    How far from its usual level
    +9.2
    Same report last year
    3.9M
    History used
    2,891 days
    2024-11-29: 3.9M2024-12-13: 3.8M2024-12-31: 4.2M2025-01-15: 4.1M2025-01-31: 3.4M2025-02-14: 4.3M2025-02-28: 4.3M2025-03-14: 4.4M2025-03-31: 4.1M2025-04-15: 3.8M2025-04-30: 4.3M2025-05-15: 4.2M2025-05-30: 3.9M2025-06-13: 4.1M2025-06-30: 5.9M2025-07-15: 6.2M2025-07-31: 6.6M2025-08-15: 7.3M2025-08-29: 7.6M2025-09-15: 8.2M2025-09-30: 8.7M2025-10-15: 8.4M2025-10-31: 9.0M2025-11-14: 11.1M2025-11-28: 11.5M
    the 28 Nov 2025 report24 earlier reportsnormal: 4.3M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  16. 2 Dec 2025Insiders record

    Wilkins Joseph D Jr. (director) bought 370 shares of QDEL ($10,345) (dated 1 Dec 2025)

  17. 26 Nov 2025several at once

    had 3 insiders buy $648K of its shares on the open market within 30 days (3 filings), while it had 11.5M shares sold short in the 28 Nov 2025 report, 2.9× the same report last year. Two unrelated kinds of activity within 63 days.

    See the evidence (6 changes)

    Short interest and volume: Short interest spike became public on 25 Oct 2025

    QuidelOrtho had 8.4M shares sold short in the 15 Oct 2025 report, 2.0× the same report last year.

    This period
    8.4M (the 15 Oct 2025 report)
    Normal report (median of 24 earlier)
    4.2M
    Typical spread (median absolute deviation)
    323K
    How far from its usual level
    +8.7
    Same report last year
    4.2M
    History used
    2,847 days
    2024-10-15: 4.2M2024-10-31: 4.1M2024-11-15: 3.8M2024-11-29: 3.9M2024-12-13: 3.8M2024-12-31: 4.2M2025-01-15: 4.1M2025-01-31: 3.4M2025-02-14: 4.3M2025-02-28: 4.3M2025-03-14: 4.4M2025-03-31: 4.1M2025-04-15: 3.8M2025-04-30: 4.3M2025-05-15: 4.2M2025-05-30: 3.9M2025-06-13: 4.1M2025-06-30: 5.9M2025-07-15: 6.2M2025-07-31: 6.6M2025-08-15: 7.3M2025-08-29: 7.6M2025-09-15: 8.2M2025-09-30: 8.7M2025-10-15: 8.4M
    the 15 Oct 2025 report24 earlier reportsnormal: 4.2M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 13 Nov 2025

    QuidelOrtho had 9.0M shares sold short in the 31 Oct 2025 report, 2.2× the same report last year.

    This period
    9.0M (the 31 Oct 2025 report)
    Normal report (median of 24 earlier)
    4.2M
    Typical spread (median absolute deviation)
    377K
    How far from its usual level
    +8.5
    Same report last year
    4.1M
    History used
    2,863 days
    2024-10-31: 4.1M2024-11-15: 3.8M2024-11-29: 3.9M2024-12-13: 3.8M2024-12-31: 4.2M2025-01-15: 4.1M2025-01-31: 3.4M2025-02-14: 4.3M2025-02-28: 4.3M2025-03-14: 4.4M2025-03-31: 4.1M2025-04-15: 3.8M2025-04-30: 4.3M2025-05-15: 4.2M2025-05-30: 3.9M2025-06-13: 4.1M2025-06-30: 5.9M2025-07-15: 6.2M2025-07-31: 6.6M2025-08-15: 7.3M2025-08-29: 7.6M2025-09-15: 8.2M2025-09-30: 8.7M2025-10-15: 8.4M2025-10-31: 9.0M
    the 31 Oct 2025 report24 earlier reportsnormal: 4.2M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Insiders: Clustered insider buying became public on 26 Nov 2025

    QuidelOrtho had 3 insiders buy $648K of its shares on the open market within 30 days (3 filings).

    Independent buyers
    3
    Purchase filings (Form 4, code P)
    3
    Total bought
    $648K
    Window
    27 Oct 2025 to 26 Nov 2025

    Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

    Short interest and volume: Short interest spike became public on 26 Nov 2025

    QuidelOrtho had 11.1M shares sold short in the 14 Nov 2025 report, 2.9× the same report last year.

    This period
    11.1M (the 14 Nov 2025 report)
    Normal report (median of 24 earlier)
    4.3M
    Typical spread (median absolute deviation)
    458K
    How far from its usual level
    +10.0
    Same report last year
    3.8M
    History used
    2,877 days
    2024-11-15: 3.8M2024-11-29: 3.9M2024-12-13: 3.8M2024-12-31: 4.2M2025-01-15: 4.1M2025-01-31: 3.4M2025-02-14: 4.3M2025-02-28: 4.3M2025-03-14: 4.4M2025-03-31: 4.1M2025-04-15: 3.8M2025-04-30: 4.3M2025-05-15: 4.2M2025-05-30: 3.9M2025-06-13: 4.1M2025-06-30: 5.9M2025-07-15: 6.2M2025-07-31: 6.6M2025-08-15: 7.3M2025-08-29: 7.6M2025-09-15: 8.2M2025-09-30: 8.7M2025-10-15: 8.4M2025-10-31: 9.0M2025-11-14: 11.1M
    the 14 Nov 2025 report24 earlier reportsnormal: 4.3M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 10 Dec 2025

    QuidelOrtho had 11.5M shares sold short in the 28 Nov 2025 report, 2.9× the same report last year.

    This period
    11.5M (the 28 Nov 2025 report)
    Normal report (median of 24 earlier)
    4.3M
    Typical spread (median absolute deviation)
    524K
    How far from its usual level
    +9.2
    Same report last year
    3.9M
    History used
    2,891 days
    2024-11-29: 3.9M2024-12-13: 3.8M2024-12-31: 4.2M2025-01-15: 4.1M2025-01-31: 3.4M2025-02-14: 4.3M2025-02-28: 4.3M2025-03-14: 4.4M2025-03-31: 4.1M2025-04-15: 3.8M2025-04-30: 4.3M2025-05-15: 4.2M2025-05-30: 3.9M2025-06-13: 4.1M2025-06-30: 5.9M2025-07-15: 6.2M2025-07-31: 6.6M2025-08-15: 7.3M2025-08-29: 7.6M2025-09-15: 8.2M2025-09-30: 8.7M2025-10-15: 8.4M2025-10-31: 9.0M2025-11-14: 11.1M2025-11-28: 11.5M
    the 28 Nov 2025 report24 earlier reportsnormal: 4.3M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 25 Dec 2025

    QuidelOrtho had 11.3M shares sold short in the 15 Dec 2025 report, 3.0× the same report last year.

    This period
    11.3M (the 15 Dec 2025 report)
    Normal report (median of 24 earlier)
    4.4M
    Typical spread (median absolute deviation)
    770K
    How far from its usual level
    +6.1
    Same report last year
    3.8M
    History used
    2,908 days
    2024-12-13: 3.8M2024-12-31: 4.2M2025-01-15: 4.1M2025-01-31: 3.4M2025-02-14: 4.3M2025-02-28: 4.3M2025-03-14: 4.4M2025-03-31: 4.1M2025-04-15: 3.8M2025-04-30: 4.3M2025-05-15: 4.2M2025-05-30: 3.9M2025-06-13: 4.1M2025-06-30: 5.9M2025-07-15: 6.2M2025-07-31: 6.6M2025-08-15: 7.3M2025-08-29: 7.6M2025-09-15: 8.2M2025-09-30: 8.7M2025-10-15: 8.4M2025-10-31: 9.0M2025-11-14: 11.1M2025-11-28: 11.5M2025-12-15: 11.3M
    the 15 Dec 2025 report24 earlier reportsnormal: 4.4M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

  18. 26 Nov 2025Short interest and volume change

    had 11.1M shares sold short in the 14 Nov 2025 report, 2.9× the same report last year.

    Same report last year: 3.8M; its normal report is 4.3M.

    See the evidence
    This period
    11.1M (the 14 Nov 2025 report)
    Normal report (median of 24 earlier)
    4.3M
    Typical spread (median absolute deviation)
    458K
    How far from its usual level
    +10.0
    Same report last year
    3.8M
    History used
    2,877 days
    2024-11-15: 3.8M2024-11-29: 3.9M2024-12-13: 3.8M2024-12-31: 4.2M2025-01-15: 4.1M2025-01-31: 3.4M2025-02-14: 4.3M2025-02-28: 4.3M2025-03-14: 4.4M2025-03-31: 4.1M2025-04-15: 3.8M2025-04-30: 4.3M2025-05-15: 4.2M2025-05-30: 3.9M2025-06-13: 4.1M2025-06-30: 5.9M2025-07-15: 6.2M2025-07-31: 6.6M2025-08-15: 7.3M2025-08-29: 7.6M2025-09-15: 8.2M2025-09-30: 8.7M2025-10-15: 8.4M2025-10-31: 9.0M2025-11-14: 11.1M
    the 14 Nov 2025 report24 earlier reportsnormal: 4.3M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  19. 26 Nov 2025Insiders change

    had 3 insiders buy $648K of its shares on the open market within 30 days (3 filings).

    Who bought: Blaser Brian J., Polan Mary Lake Ph D, Busky Joseph M..

    See the evidence (3 source records)
    Independent buyers
    3
    Purchase filings (Form 4, code P)
    3
    Total bought
    $648K
    Window
    27 Oct 2025 to 26 Nov 2025

    Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

  20. 26 Nov 2025Insiders record

    Busky Joseph M. (Chief Financial Officer) bought 4,770 shares of QDEL ($124,306) (dated 25 Nov 2025)

  21. 25 Nov 2025Insiders record

    POLAN MARY LAKE PH D (director) bought 1,000 shares of QDEL ($22,430) (dated 24 Nov 2025)

  22. 21 Nov 2025Insiders record

    Blaser Brian J. (President and CEO) bought 23,500 shares of QDEL ($501,490) (dated 20 Nov 2025)

  23. 13 Nov 2025Short interest and volume change

    had 9.0M shares sold short in the 31 Oct 2025 report, 2.2× the same report last year.

    Same report last year: 4.1M; its normal report is 4.2M.

    See the evidence
    This period
    9.0M (the 31 Oct 2025 report)
    Normal report (median of 24 earlier)
    4.2M
    Typical spread (median absolute deviation)
    377K
    How far from its usual level
    +8.5
    Same report last year
    4.1M
    History used
    2,863 days
    2024-10-31: 4.1M2024-11-15: 3.8M2024-11-29: 3.9M2024-12-13: 3.8M2024-12-31: 4.2M2025-01-15: 4.1M2025-01-31: 3.4M2025-02-14: 4.3M2025-02-28: 4.3M2025-03-14: 4.4M2025-03-31: 4.1M2025-04-15: 3.8M2025-04-30: 4.3M2025-05-15: 4.2M2025-05-30: 3.9M2025-06-13: 4.1M2025-06-30: 5.9M2025-07-15: 6.2M2025-07-31: 6.6M2025-08-15: 7.3M2025-08-29: 7.6M2025-09-15: 8.2M2025-09-30: 8.7M2025-10-15: 8.4M2025-10-31: 9.0M
    the 31 Oct 2025 report24 earlier reportsnormal: 4.2M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  24. 25 Oct 2025Short interest and volume change

    had 8.4M shares sold short in the 15 Oct 2025 report, 2.0× the same report last year.

    Same report last year: 4.2M; its normal report is 4.2M.

    See the evidence
    This period
    8.4M (the 15 Oct 2025 report)
    Normal report (median of 24 earlier)
    4.2M
    Typical spread (median absolute deviation)
    323K
    How far from its usual level
    +8.7
    Same report last year
    4.2M
    History used
    2,847 days
    2024-10-15: 4.2M2024-10-31: 4.1M2024-11-15: 3.8M2024-11-29: 3.9M2024-12-13: 3.8M2024-12-31: 4.2M2025-01-15: 4.1M2025-01-31: 3.4M2025-02-14: 4.3M2025-02-28: 4.3M2025-03-14: 4.4M2025-03-31: 4.1M2025-04-15: 3.8M2025-04-30: 4.3M2025-05-15: 4.2M2025-05-30: 3.9M2025-06-13: 4.1M2025-06-30: 5.9M2025-07-15: 6.2M2025-07-31: 6.6M2025-08-15: 7.3M2025-08-29: 7.6M2025-09-15: 8.2M2025-09-30: 8.7M2025-10-15: 8.4M
    the 15 Oct 2025 report24 earlier reportsnormal: 4.2M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  25. 10 Oct 2025Short interest and volume change

    had 8.7M shares sold short in the 30 Sep 2025 report, 2.1× the same report last year.

    Same report last year: 4.2M; its normal report is 4.2M.

    See the evidence
    This period
    8.7M (the 30 Sep 2025 report)
    Normal report (median of 24 earlier)
    4.2M
    Typical spread (median absolute deviation)
    240K
    How far from its usual level
    +10.7
    Same report last year
    4.2M
    History used
    2,832 days
    2024-09-30: 4.2M2024-10-15: 4.2M2024-10-31: 4.1M2024-11-15: 3.8M2024-11-29: 3.9M2024-12-13: 3.8M2024-12-31: 4.2M2025-01-15: 4.1M2025-01-31: 3.4M2025-02-14: 4.3M2025-02-28: 4.3M2025-03-14: 4.4M2025-03-31: 4.1M2025-04-15: 3.8M2025-04-30: 4.3M2025-05-15: 4.2M2025-05-30: 3.9M2025-06-13: 4.1M2025-06-30: 5.9M2025-07-15: 6.2M2025-07-31: 6.6M2025-08-15: 7.3M2025-08-29: 7.6M2025-09-15: 8.2M2025-09-30: 8.7M
    the 30 Sep 2025 report24 earlier reportsnormal: 4.2M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  26. 25 Sep 2025Short interest and volume change

    had 8.2M shares sold short in the 15 Sep 2025 report, 2.0× the same report last year.

    Same report last year: 4.0M; its normal report is 4.2M.

    See the evidence
    This period
    8.2M (the 15 Sep 2025 report)
    Normal report (median of 24 earlier)
    4.2M
    Typical spread (median absolute deviation)
    199K
    How far from its usual level
    +9.5
    Same report last year
    4.0M
    History used
    2,817 days
    2024-09-13: 4.0M2024-09-30: 4.2M2024-10-15: 4.2M2024-10-31: 4.1M2024-11-15: 3.8M2024-11-29: 3.9M2024-12-13: 3.8M2024-12-31: 4.2M2025-01-15: 4.1M2025-01-31: 3.4M2025-02-14: 4.3M2025-02-28: 4.3M2025-03-14: 4.4M2025-03-31: 4.1M2025-04-15: 3.8M2025-04-30: 4.3M2025-05-15: 4.2M2025-05-30: 3.9M2025-06-13: 4.1M2025-06-30: 5.9M2025-07-15: 6.2M2025-07-31: 6.6M2025-08-15: 7.3M2025-08-29: 7.6M2025-09-15: 8.2M
    the 15 Sep 2025 report24 earlier reportsnormal: 4.2M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  27. 11 Sep 2025Short interest and volume change

    had 7.6M shares sold short in the 29 Aug 2025 report, 1.8× the same report last year.

    Same report last year: 4.3M; its normal report is 4.2M.

    See the evidence
    This period
    7.6M (the 29 Aug 2025 report)
    Normal report (median of 24 earlier)
    4.2M
    Typical spread (median absolute deviation)
    162K
    How far from its usual level
    +8.3
    Same report last year
    4.3M
    History used
    2,800 days
    2024-08-30: 4.3M2024-09-13: 4.0M2024-09-30: 4.2M2024-10-15: 4.2M2024-10-31: 4.1M2024-11-15: 3.8M2024-11-29: 3.9M2024-12-13: 3.8M2024-12-31: 4.2M2025-01-15: 4.1M2025-01-31: 3.4M2025-02-14: 4.3M2025-02-28: 4.3M2025-03-14: 4.4M2025-03-31: 4.1M2025-04-15: 3.8M2025-04-30: 4.3M2025-05-15: 4.2M2025-05-30: 3.9M2025-06-13: 4.1M2025-06-30: 5.9M2025-07-15: 6.2M2025-07-31: 6.6M2025-08-15: 7.3M2025-08-29: 7.6M
    the 29 Aug 2025 report24 earlier reportsnormal: 4.2M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  28. 27 Aug 2025Short interest and volume change

    had 7.3M shares sold short in the 15 Aug 2025 report, 1.8× the same report last year.

    Same report last year: 4.0M; its normal report is 4.2M.

    See the evidence
    This period
    7.3M (the 15 Aug 2025 report)
    Normal report (median of 24 earlier)
    4.2M
    Typical spread (median absolute deviation)
    160K
    How far from its usual level
    +7.5
    Same report last year
    4.0M
    History used
    2,786 days
    2024-08-15: 4.0M2024-08-30: 4.3M2024-09-13: 4.0M2024-09-30: 4.2M2024-10-15: 4.2M2024-10-31: 4.1M2024-11-15: 3.8M2024-11-29: 3.9M2024-12-13: 3.8M2024-12-31: 4.2M2025-01-15: 4.1M2025-01-31: 3.4M2025-02-14: 4.3M2025-02-28: 4.3M2025-03-14: 4.4M2025-03-31: 4.1M2025-04-15: 3.8M2025-04-30: 4.3M2025-05-15: 4.2M2025-05-30: 3.9M2025-06-13: 4.1M2025-06-30: 5.9M2025-07-15: 6.2M2025-07-31: 6.6M2025-08-15: 7.3M
    the 15 Aug 2025 report24 earlier reportsnormal: 4.2M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  29. 12 Aug 2025Short interest and volume change

    had 6.6M shares sold short in the 31 Jul 2025 report, 1.5× the same report last year.

    Same report last year: 4.4M; its normal report is 4.2M.

    See the evidence
    This period
    6.6M (the 31 Jul 2025 report)
    Normal report (median of 24 earlier)
    4.2M
    Typical spread (median absolute deviation)
    160K
    How far from its usual level
    +5.8
    Same report last year
    4.4M
    History used
    2,771 days
    2024-07-31: 4.4M2024-08-15: 4.0M2024-08-30: 4.3M2024-09-13: 4.0M2024-09-30: 4.2M2024-10-15: 4.2M2024-10-31: 4.1M2024-11-15: 3.8M2024-11-29: 3.9M2024-12-13: 3.8M2024-12-31: 4.2M2025-01-15: 4.1M2025-01-31: 3.4M2025-02-14: 4.3M2025-02-28: 4.3M2025-03-14: 4.4M2025-03-31: 4.1M2025-04-15: 3.8M2025-04-30: 4.3M2025-05-15: 4.2M2025-05-30: 3.9M2025-06-13: 4.1M2025-06-30: 5.9M2025-07-15: 6.2M2025-07-31: 6.6M
    the 31 Jul 2025 report24 earlier reportsnormal: 4.2M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  30. 25 Jul 2025Short interest and volume change

    had 6.2M shares sold short in the 15 Jul 2025 report, 1.7× the same report last year.

    Same report last year: 3.7M; its normal report is 4.1M.

    See the evidence
    This period
    6.2M (the 15 Jul 2025 report)
    Normal report (median of 24 earlier)
    4.1M
    Typical spread (median absolute deviation)
    155K
    How far from its usual level
    +5.1
    Same report last year
    3.7M
    History used
    2,755 days
    2024-07-15: 3.7M2024-07-31: 4.4M2024-08-15: 4.0M2024-08-30: 4.3M2024-09-13: 4.0M2024-09-30: 4.2M2024-10-15: 4.2M2024-10-31: 4.1M2024-11-15: 3.8M2024-11-29: 3.9M2024-12-13: 3.8M2024-12-31: 4.2M2025-01-15: 4.1M2025-01-31: 3.4M2025-02-14: 4.3M2025-02-28: 4.3M2025-03-14: 4.4M2025-03-31: 4.1M2025-04-15: 3.8M2025-04-30: 4.3M2025-05-15: 4.2M2025-05-30: 3.9M2025-06-13: 4.1M2025-06-30: 5.9M2025-07-15: 6.2M
    the 15 Jul 2025 report24 earlier reportsnormal: 4.1M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  31. 27 May 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  32. 27 May 2025Filings record

    Director or officer change

  33. 4 Mar 2025Filings record

    Changed its auditor

  34. 14 Dec 2024Insiders record

    Blaser Brian J. (President and CEO) bought 6,033 shares of QDEL ($249,887) (dated 13 Dec 2024)

  35. 10 Dec 2024Filings record

    Director or officer change

  36. 21 Nov 2024Filings record

    Director or officer change

  37. 18 Nov 2024Filings record

    Director or officer change

  38. 8 Nov 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  39. 8 Nov 2024Filings record

    Director or officer change

  40. 7 May 2024Filings record

    Director or officer change

Showing the newest 40 of 72 entries; narrow the window or the kind of data to see older ones.

Not listed: 73 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001906324
Ticker
QDEL
Domain
quidelortho.com
Employer name
Diagnostic HYBRIDS, Inc., Ortho-Clinical Diagnostics, Inc. (2 unverified)
Fein
22-3329332, 31-1050325 (2 unverified)
Hq location
CA|SAN DIEGO|92121 (1 unverified)
Lobbying client
apco worldwide llc on behalf of quidelortho, christie law firm llc on behalf of ortho clinical diagnostics, ortho clinical diagnostics
Name
BioHelix Corporation, Branch of Ortho-Clinical Diagnostics Netherlands B.V. (Saudi Arabia branch), Coronado Topco, Inc., Crimson Germany GmbH and 72 more
Uei
ZFXRG96JMJ39
Wikipedia
QuidelOrtho
  • DOL H-1B labor condition applications and PERM certifications18 data points17 Nov 2025 to 21 Sep 2026
  • Federal lobbying disclosures (LDA)5 records, 72 data points1 May 2020 to 30 Sep 2026
  • SEC Form 13F institutional holdings481 data points30 Jun 2013 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)67 records6 Jun 2022 to 3 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)363 data points29 Dec 2019 to 28 Oct 2026
  • SEC Form 4 insider transactions35 records, 124 data points22 Feb 2023 to 19 Feb 2026
  • FINRA short interest (twice monthly)624 data points29 Dec 2017 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)4178 data points1 Aug 2018 to 20 Nov 2026
  • USASpending.gov federal awards123 data points13 Aug 2026 to 19 Nov 2026
  • Wikipedia pageviews10 data points11 Nov 2026 to 20 Nov 2026